Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination

Citations Over TimeTop 10% of 2017 papers

Abstract

Metastasis-competent circulating tumour cells (CTCs) experience oxidative stress in the bloodstream, but their survival mechanisms are not well defined. Here, comparing single-cell RNA-Seq profiles of CTCs from breast, prostate and lung cancers, we observe consistent induction of β-globin (HBB), but not its partner α-globin (HBA). The tumour-specific origin of HBB is confirmed by sequence polymorphisms within human xenograft-derived CTCs in mouse models. Increased intracellular reactive oxygen species (ROS) in cultured breast CTCs triggers HBB induction, mediated through the transcriptional regulator KLF4. Depletion of HBB in CTC-derived cultures has minimal effects on primary tumour growth, but it greatly increases apoptosis following ROS exposure, and dramatically reduces CTC-derived lung metastases. These effects are reversed by the anti-oxidant N-Acetyl Cysteine. Conversely, overexpression of HBB is sufficient to suppress intracellular ROS within CTCs. Altogether, these observations suggest that β-globin is selectively deregulated in cancer cells, mediating a cytoprotective effect during blood-borne metastasis.

Related Papers

• → Circulating Tumor Cell Enrichment Based on Physical Properties(2013)162 cited
• → State-of-the-arts techniques and current evolving approaches in the separation and detection of circulating tumor cell(2021)33 cited
• → Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells(2022)30 cited
• → Micro-/nanotechnology-based isolation and clinical significance of circulating tumor cells(2012)7 cited
• Isolation of circulating tumor cells under hydrodynamic loading using microfluidic technology(基于微流控技术在流体动力载荷下分离循环肿瘤细胞)(2014)